Trials / Terminated
TerminatedNCT02460107
Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy
- Status
- Terminated
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Catholic University of Korea Saint Paul's Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether botulinum toxin A is effective in the treatment of neuropathic pain in patients with diabetic peripheral polyneuropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Botulinum toxin type A | |
| OTHER | Normal saline | Placebo |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2016-11-30
- Completion
- 2016-12-31
- First posted
- 2015-06-02
- Last updated
- 2017-08-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02460107. Inclusion in this directory is not an endorsement.